XML 33 R42.htm IDEA: XBRL DOCUMENT

17. Parent Company Financial Statements (Tables)

12 Months Ended

Dec. 31, 2014

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Parent Balance Sheets

Aemetis, Inc. (Parent Company)

Consolidated Balance Sheets

As of December 31, 2014 and 2013



Assets		2014				2013
Current assets
Cash and cash equivalents			65				14
Intercompany receivables			24,578				27,627
Prepaid expenses			609				-
Total current assets			25,252				27,641

Investments in Subsidiaries, net of advances
Investment in Aemetis International, Inc.			1,082				2,679
Investment in Aemetis Americas, Inc			-				-
Total investments in Subsidiaries, net of advances			1,082				2,679

Other assets			23				23

Total Assets		$	26,357			$	30,343

Liabilities & stockholders' deficit
Current liabilities
Accounts payable			2,869				3,397
Outstanding checks in excess of cash			-				-
Mandatorily redeemable Series B convertibe preferred			2,641				2,540
Other current liabilities			996				1,678
Total current liabilities			6,506				7,615


Subsidiary obligation in excess of investment
Investment in AE Advanced Fuels, Inc.			18,497				31,325
Investment in Aemetis Americas, Inc			205				247
Investment in Aemetis Biofuels, Inc.			2,741				2,741
Investment in Aemetis Technologies, Inc.			1,031				833
Investment in Biofuels Marketing, Inc.			349				349
Total subsidiary obligation in excess of investment			22,823				35,495

Total long term liabilities		$	22,823			$	35,495

Stockholders' deficit
Series B Preferred convertible stock			2				2
Common stock			21				20
Additional paid-in capital			87,080				84,373
Accumulated deficit			(87,113	)			(94,246	)
Accumulated other comprehensive loss			(2,962	)			(2,916	)
Total stockholders' deficit			(2,972	)			(12,767	)
Total liabilities & stockholders' deficit		$	26,357			$	30,343

Schedule Parent Statements of Operations and Comprehensive Loss

Aemetis, Inc. (Parent Company)

Consolidated Statements of Operations and Comprehensive Loss

For the Years Ended December 31, 2014, 2013 and 2012



		2014				2013				2012

Equity in subsidiary gains (losses)			11,123				(22,134	)			(12	)

Selling, general and administrative expenses			3,942				2,687				2,303

Operating income (loss)			7,181				(24,821	)			(2,315	)

Other income (expense)
Interest expense			(277	)			(187	)			(1,866	)
Other income (expense)			235				577				(97	)

Income (loss) before income taxes			7,139				(24,431	)			(4,278	)

Income tax expense			(6	)			(6	)			(4	)

Net gain (loss)			7,133				(24,437	)			(4,282	)

Other comprehensive loss
Foreign currency translation adjustment			(46	)			(598	)			(75	)
Comprehensive income (loss)			7,087				(25,035	)			(4,357	)

Parent Statements of Cash Flows

Aemetis, Inc. (Parent Company)

Consolidated Statements of Cash Flows

For the years ended December 31, 2014, 2013 and 2012


		2014				2013				2012
Operating activities:
Net income (loss)			7,133				(24,437	)			(4,282	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:

Stock-based compensation			624				1,760				686
Amortization of debt issuance discount			-				-				401
Change in fair value of warrant liability			48				(197	)			97
Changes in assets and liabilities:
Subsidiary portion of net (gains) losses			(11,123	)			22,134				12
Prepaid expenses			106				-				5
Accounts payable			(512	)			(640	)			237
Accrued interest expense			-				-				683
Other liabilities			(629	)			(178	)			288
Net cash used in operating activities			(4,353	)			(1,558	)			(1,873	)

Investing activities:
Change in outstanding checks in excess of cash			-				(26	)			26
Subsidiary advances, net			4,399				515				9,417
Net cash provided in investing activities			4,399				489				9,443

Financing activities:
Proceeds from borrowings under secured debt facilities			-				-				840
Repayments of borrowings under secured debt facilities			-				-				(8,412	)
Equity Offering			-				1,075				-
Issuance of common stock for services, option and warrant exercises			5				8				1
Net cash provided by (used in) financing activities			5				1,083				(7,571	)

Net increase in cash and cash equivalents			51				14				(1	)

Cash and cash equivalents at beginning of period			14				-				1
Cash and cash equivalents at end of period		$	65			$	14			$	(0	)

Supplemental disclosures of cash flow information, cash paid:

Interest payments			6,824				4,522				2,085
Income tax expense			6				6				4

Supplemental disclosures of cash flow information, non-cash transactions:

Proceeds from exercise of stock options applied to accounts payable			16				-				-
Issuance of warrants to non-employees to secure procurement and working capital			-				336				-
Issuance of warrants to subordinated debt holders			1,301				1,127				-
Exercise of conversion feature on note to equity			47				-				-
Stock issued in connection with services			715				-				-
Issuance of shares for acquisition			-				-				12,511
Payments of principal, fees and interest by issuance of stock			-				3,616				11,886